Copyright
©The Author(s) 2021.
World J Hepatol. Jun 27, 2021; 13(6): 686-698
Published online Jun 27, 2021. doi: 10.4254/wjh.v13.i6.686
Published online Jun 27, 2021. doi: 10.4254/wjh.v13.i6.686
Table 1 Characteristics of patients and hospitals and individual effects on mortality, length of stay and total charges
Study time period | 1998-2017 | Individual effect (Type III test, P value) | ||
Mortality | Length of stay | Total charges | ||
BCS patients' characteristics | ||||
Age | 50.50 (0.19) | < 0.001 | 0.052 | < 0.001 |
Female | 55.19 (0.54) | 0.003 | 0.001 | < 0.001 |
Race | 0.138 | 0.013 | < 0.001 | |
1: White | 56.03 (0.54) | |||
2: Black | 13.26 (0.37) | |||
3: Hispanic | 9.56 (0.32) | |||
4: Asian/Pacific Islander | 2.56 (0.17) | |||
6: Other | 3.65 (0.2) | |||
9: Unknown | 14.93 (0.39) | |||
Primary payer | < 0.001 | 0.002 | < 0.001 | |
1: Medicare | 33.17 (0.52) | |||
2: Medicaid | 18.42 (0.42) | |||
3: Private insurance | 40.20 (0.54) | |||
6: Other | 8.21 (0.3) | |||
Hospital characteristics | ||||
Hospital size | 0.014 | < 0.001 | < 0.001 | |
1: Small | 9.81 (0.32) | |||
2: Medium | 18.92 (0.43) | |||
3: Large | 71.27 (0.49) | |||
Hospital location and teaching status | 0.195 | < 0.001 | < 0.001 | |
1: Rural | 6.89 (0.28) | |||
2: Urban nonteaching | 24.24 (0.47) | |||
3: Urban teaching | 68.87 (0.51) | |||
Hospital region | 0.533 | 0.010 | < 0.001 | |
1: Northeast | 21.84 (0.45) | |||
2: Midwest | 22.15 (0.46) | |||
3: South | 33.45 (0.52) | |||
4: West | 22.57 (0.46) | |||
Clinical characteristics | ||||
Ascites | 29.93 (0.5) | < 0.001 | < 0.001 | < 0.001 |
Acute kidney injury | 18.84 (0.43) | < 0.001 | < 0.001 | < 0.001 |
Hepatic cirrhosis with no mention of alcohol | 18.65 (0.43) | 0.901 | 0.031 | 0.838 |
Cancer | 17.26 (0.41) | < 0.001 | 0.002 | 0.010 |
Portal hypertension | 16.57 (0.41) | 0.029 | 0.898 | 0.000 |
Hepatic encephalopathy | 9.59 (0.32) | < 0.001 | < 0.001 | < 0.001 |
Portal vein thrombosis | 7.92 (0.3) | 0.006 | 0.372 | 0.073 |
Esophageal varices without bleeding | 7.44 (0.29) | 0.002 | 0.324 | 0.091 |
Acute respiratory Failure | 7.03 (0.28) | < 0.001 | < 0.001 | < 0.001 |
HCC | 6.93 (0.28) | < 0.001 | < 0.001 | 0.543 |
Acute blood loss anemia/hemorrhagic | 6.62 (0.27) | 0.008 | < 0.001 | < 0.001 |
IVC thrombosis | 6.39 (0.27) | < 0.001 | < 0.001 | < 0.001 |
Sepsis | 6.10 (0.26) | < 0.001 | < 0.001 | < 0.001 |
Alcoholic cirrhosis | 5.73 (0.25) | 0.113 | 0.731 | 0.140 |
Acute liver failure | 5.60 (0.25) | < 0.001 | < 0.001 | < 0.001 |
Hepatorenal syndrome | 3.29 (0.2) | < 0.001 | < 0.001 | < 0.001 |
Variceal bleeding | 3.20 (0.19) | 0.107 | 0.160 | 0.001 |
Spontaneous bacterial peritonitis | 2.83 (0.18) | < 0.001 | < 0.001 | < 0.001 |
Intestinal infarct/acute vascular insufficiency | 2.11 (0.16) | < 0.001 | < 0.001 | < 0.001 |
Elixhauser Comoridity Score excluding liver disease | 9.38 (0.12) | < 0.001 | < 0.001 | < 0.001 |
Table 2 Trends in outcomes of interest
1998-2017 (unweighted: 8435, weighted: 41119) | 1998 (unweighted: 262, weighted: 1367) | 2017 (unweighted: 680, weighted: 3400) | APC (95%CI) | P value for APC | |
Procedures | |||||
Number of procedures | 2.64 (0.03) | 3.09 (0.20) | 2.42 (0.13) | -0.51% (-1.09%, 0.06%) | 0.082 |
Paracentesis | 18.41 (0.42) | 28.56 (2.82) | 16.47 (1.42) | -1.67% (-2.53%, -0.81%) | 0.000 |
Upper endoscopy | 10.94 (0.34) | 13.08 (2.06) | 11.91 (1.24) | -0.17% (-1.31%, 0.97%) | 0.766 |
Liver biopsy | 6.24 (0.26) | 10.35 (1.9) | 5.15 (0.85) | -4.01% (-5.42%, -2.58%) | < 0.0001 |
Portosystemic shunt/TIPS | 3.63 (0.2) | 6.12 (1.54) | 2.94 (0.65) | -4.95% (-6.78%, -3.09%) | < 0.0001 |
Liver transplantation | 1.9 (0.15) | 1.29 (0.75) | 2.06 (0.54) | -2.68% (-5.26%, -0.02%) | 0.048 |
Disposition of patient | |||||
1: Discharged to home or selfcare | 58.8(0.54) | 50.71 (3.12) | 55.96 (1.91) | -0.28% (-0.77%, 0.21%) | 0.262 |
6: Home health care | 13.49 (0.37) | 12.04 (2.04) | 17.23 (1.45) | 3.31% (2.20%, 4.43%) | < 0.0001 |
5: Transfer: other type of facility | 11.12 (0.34) | 10.21 (1.89) | 12.08 (1.25) | 1.87% (0.70%, 3.06%) | 0.002 |
20: Died in hospital | 8.74 (0.31) | 18.17 (2.44) | 7.66 (1.02) | -4.31% (-5.50%, -3.10%) | < 0.0001 |
2: Transfer: short-term hospital | 6.8 (0.28) | 8.25 (1.71) | 5.6 (0.88) | -1.26% (-2.66%, 0.17%) | 0.084 |
7: Against medical advice | 1 (0.11) | 0.61 (0.43) | 1.47 (0.46) | 2.94% (-1.02%, 7.07%) | 0.148 |
Outcomes | |||||
Number of deaths | 737 (Unweighted); 3591 (Weighted) | 46 (Unweighted); 249 (Weighted) | 52 (Unweighted); 260 (Weighted) | ||
Mortality rate per 1000000 United States populations | 0.9 | 0.8 | -0.29% (-0.86%, 0.27%) | 0.309 | |
Mortality rate per 1000000 inpatients | 8.87 | 8.55 | 0.34% (-0.23%, 0.92%) | 0.243 | |
Mortality rate among BCS inpatients | 0.09 | 0.18 | 0.08 | -4.41% (-4.95%, -3.88%) | < 0.0001 |
Length of stay (d) | 8.84 (0.13) | 12.73 (1.01) | 7.64 (0.36) | -2.04% (-2.67%, -1.41%) | < 0.0001 |
Average total charges in 2017 dollars | 94440.04 (1996.06) | 95515.01 (9483.24) | 103850.98 (8183.79) | 1.15% (0.35%, 1.96%) | 0.005 |
Table 3 Multivariate model on mortality
Response | Beta estimate | Standard error | P value for beta | Odds ratio (95%CI) | |
Age | 0.024 | 0.003 | < 0.0001 | 1.024 (1.019, 1.029) | |
Acute respiratory Failure | Yes (reference = No) | 1.652 | 0.109 | < 0.0001 | 5.219 (4.211, 6.468) |
Intestinal infarct/acute vascular insufficiency | Yes (reference = No) | 1.422 | 0.201 | < 0.0001 | 4.143 (2.795, 6.142) |
Acute liver failure | Yes (reference = No) | 1.286 | 0.119 | < 0.0001 | 3.617 (2.864, 4.567) |
Hepatorenal syndrome | Yes (reference = No) | 1.123 | 0.147 | < 0.0001 | 3.072 (2.302, 4.101) |
Cancer | Yes (reference = No) | 0.882 | 0.098 | < 0.0001 | 2.415 (1.993, 2.927) |
Acute kidney injury | Yes (reference = No) | 0.803 | 0.092 | < 0.0001 | 2.232 (1.862, 2.675) |
Sepsis/severe sepsis/septic shock | Yes (reference = No) | 0.635 | 0.122 | < 0.0001 | 1.886 (1.484, 2.398) |
Hepatic encephalopathy | Yes (reference = No) | 0.280 | 0.117 | 0.020 | 1.323 (1.052, 1.662) |
Elixhauser Comorbidity Score excluding liver disease | 0.026 | 0.004 | < 0.0001 | 1.027 (1.019, 1.034) |
Table 4 Multivariate model on length of stay
Response | Beta estimate | Standard error | P value for Beta | P value for type 3 test | |
Primary payer | 1: Medicare (reference) | 0.000 | - | - | 0.022 |
2: Medicaid | 0.053 | 0.037 | 0.144 | ||
3: Private insurance | 0.084 | 0.030 | 0.005 | ||
Hospital bed size | 1: Small (reference) | 0.000 | - | - | < 0.0001 |
2: Medium | 0.113 | 0.049 | 0.021 | ||
3: Large | 0.293 | 0.042 | <.0001 | ||
Hospital location and teaching status | 1: Rural (reference) | 0.000 | - | - | < 0.0001 |
2: Urban nonteaching | 0.206 | 0.054 | <.0001 | ||
3: Urban teaching | 0.433 | 0.050 | <.0001 | ||
Hospital region | 1: Northeast | 0.171 | 0.038 | <.0001 | < 0.0001 |
2: Midwest | 0.017 | 0.038 | <.0001 | ||
3: South | 0.055 | 0.034 | <.0001 | ||
4: West (reference) | 0.000 | ||||
Complications | |||||
Acute liver failure | Yes (reference = No) | 0.223 | 0.057 | < 0.0001 | < 0.0001 |
Acute respiratory Failure | Yes (reference = No) | 0.380 | 0.052 | < 0.0001 | < 0.0001 |
Acute kidney injury | Yes (reference = No) | 0.255 | 0.035 | < 0.0001 | < 0.0001 |
Ascites | Yes (reference = No) | 0.118 | 0.028 | < 0.0001 | < 0.0001 |
Spontaneous bacterial peritonitis | Yes (reference = No) | 0.480 | 0.076 | < 0.0001 | < 0.0001 |
IVC thrombosis | Yes (reference = No) | 0.138 | 0.052 | 0.008 | 0.008 |
Intestinal infarct/acute vascular insufficiency | Yes (reference = No) | 0.383 | 0.088 | < 0.0001 | < 0.0001 |
cancer | Yes (reference = No) | -0.278 | 0.036 | < 0.0001 | < 0.0001 |
Elixhauser Comorbidity Score excluding liver disease | 0.019 | 0.001 | < 0.0001 | < 0.0001 |
Table 5 Multivariate model on total charges
Response | Estimate | Standard error | P value for beta | P value for type 3 test | |
Race | 1: White (reference) | 0.000 | - | - | < 0.0001 |
2: Black | -0.037 | 0.026 | 0.162 | ||
3: Hispanic | 0.015 | 0.031 | 0.613 | ||
4: Asian/Pacific Islander | 0.136 | 0.058 | 0.019 | ||
6: Other | 0.082 | 0.046 | 0.077 | ||
9: Unknown | -0.185 | 0.025 | < 0.0001 | ||
Hospital bed size | 1: Small (reference) | 0.000 | - | - | < 0.0001 |
2: Medium | 0.080 | 0.034 | 0.018 | ||
3: Large | 0.169 | 0.029 | < 0.0001 | ||
Hospital location and teaching status | 1: Rural (reference) | 0.000 | - | - | < 0.0001 |
2: Urban nonteaching | 0.428 | 0.037 | < 0.0001 | ||
3: Urban teaching | 0.552 | 0.034 | < 0.0001 | ||
Hospital region | 1: Northeast | -0.195 | 0.027 | < 0.0001 | < 0.0001 |
2: Midwest | -0.333 | 0.027 | < 0.0001 | ||
3: South | -0.330 | 0.024 | < 0.0001 | ||
4: West (reference) | 0.000 | - | - | ||
Complications | |||||
Acute liver failure | Yes (reference = No) | 0.078 | 0.039 | 0.044 | 0.044 |
Acute respiratory Failure | Yes (reference = No) | 0.204 | 0.036 | < 0.0001 | < 0.0001 |
Acute kidney injury | Yes (reference = No) | 0.146 | 0.025 | < 0.0001 | < 0.0001 |
Hepatorenal syndrome | Yes (reference = No) | -0.132 | 0.050 | 0.008 | 0.009 |
IVC thrombosis | Yes (reference = No) | 0.075 | 0.035 | 0.035 | 0.035 |
Acute blood loss anemia/ hemorrhagic | Yes (reference = No) | 0.155 | 0.035 | < 0.0001 | < 0.0001 |
Cancer | Yes (reference = No) | -0.052 | 0.025 | 0.037 | 0.037 |
Elixhauser Comoridity Score excluding liver disease | 0.005 | 0.001 | < 0.0001 | < 0.0001 | |
Other variables | |||||
Number of procedures | 0.118 | 0.004 | < 0.0001 | < 0.0001 | |
Length of stay | 0.054 | 0.001 | < 0.0001 | < 0.0001 |
- Citation: Alukal JJ, Zhang T, Thuluvath PJ. Mortality and health care burden of Budd Chiari syndrome in the United States: A nationwide analysis (1998-2017). World J Hepatol 2021; 13(6): 686-698
- URL: https://www.wjgnet.com/1948-5182/full/v13/i6/686.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i6.686